|Bid||215.18 x 1100|
|Ask||222.88 x 800|
|Day's Range||218.58 - 222.17|
|52 Week Range||187.16 - 351.86|
|Beta (5Y Monthly)||0.39|
|PE Ratio (TTM)||21.63|
|Earnings Date||Apr 20, 2022 - Apr 25, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||234.25|
The "brain health pandemic" since Covid struck exposed a glaring void: Current depression treatments don't fit many patients' needs. A group of biotech stocks hope to change that.
Ionis (IONS) incurs a wider-than-expected loss in Q2. Its sales also miss estimates. Stock moves down in response to the results.
Apple is growing its Triangle footprint by filling an entire office building in Durham as the tech giant awaits the build out of a technology hub expected to one day house 3,000 employees in Research Triangle Park.